Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.GAC0003A4 has been used in the study of advanced pancreatic cancers and other recalcitrant malignancies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 96.00 | |
5 mg | In stock | $ 239.00 | |
10 mg | In stock | $ 378.00 | |
25 mg | In stock | $ 628.00 | |
50 mg | In stock | $ 886.00 | |
100 mg | In stock | $ 1,190.00 |
Description | GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.GAC0003A4 has been used in the study of advanced pancreatic cancers and other recalcitrant malignancies. |
Synonyms | GAC0001E5 |
Molecular Weight | 340.42 |
Formula | C20H24N2O3 |
CAS No. | 929492-71-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (235.00 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GAC0003A4 929492-71-7 Metabolism Liver X Receptor GAC 0001E5 GAC-0001E5 GAC0001E5 inhibitor inhibit